Valuation: Tempus AI, Inc.

Market Cap 15.35B 23,403B 13.5B 12.77B 11.58B 21.76B 1,473B 21.87B 153B 58.93B 752B 57.63B 56.38B 2,416B P/E 2026 *
-61.1x
P/E 2027 * -65.2x
Enterprise Value 15.95B 24,317B 14.03B 13.27B 12.03B 22.61B 1,531B 22.73B 159B 61.23B 781B 59.88B 58.58B 2,510B EV / Sales 2026 *
9.99x
EV / Sales 2027 * 8.05x
Free-Float
61.4%
Yield 2026 *
-
Yield 2027 * -
1 day+0.09%
1 week+10.72%
Current month+37.16%
1 month+21.72%
3 months+59.83%
6 months+119.54%
Current year+49.80%
1 week 9,880
Extreme 9880
11,630
1 month 7,720
Extreme 7720
11,630
Current year 5,165
Extreme 5165
11,630
1 year 5,165
Extreme 5165
13,350
3 years 5,160
Extreme 5160
13,350
5 years 5,160
Extreme 5160
13,350
10 years 5,160
Extreme 5160
13,350
Manager TitleAgeSince
Chief Executive Officer 56 2015-07-31
Director of Finance/CFO 40 2017-07-31
Chief Administrative Officer 55 2020-05-31
Director TitleAgeSince
Chairman 56 2015-07-31
Director/Board Member 53 2019-10-28
Director/Board Member 74 2017-08-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%+10.72% - - 15.34B
+2.64%+7.07%+11.87%+38.40% 47.97B
+0.22%+1.71%+50.91%+34.00% 44.5B
-1.58%+5.65%+359.34%+598.06% 43.93B
+1.70%+4.61%+12.56%+90.97% 41.03B
+0.51%-0.61%+5.18%+46.87% 29.85B
-0.48%+0.59%+23.98%+148.36% 17.27B
+0.08%+9.30%+8.41% - 15.34B
+1.76%+2.98%+29.13%+45.78% 15.3B
+1.97%-2.82% - - 14.82B
Average +0.63%+2.46%+62.67%+143.21% 30B
Weighted average by Cap. +0.68%+2.97%+79.47%+158.52%

Financials

2026 *2027 *
Net sales 1.6B 2,433B 1.4B 1.33B 1.2B 2.26B 153B 2.27B 15.86B 6.13B 78.18B 5.99B 5.86B 251B 1.97B 2,999B 1.73B 1.64B 1.48B 2.79B 189B 2.8B 19.55B 7.55B 96.37B 7.39B 7.23B 310B
Net income -246M -375B -216M -205M -186M -349M -23.62B -351M -2.45B -945M -12.05B -924M -904M -38.73B -236M -360B -208M -197M -178M -335M -22.69B -337M -2.35B -908M -11.58B -888M -868M -37.21B
Net Debt 599M 913B 527M 498M 452M 849M 57.5B 854M 5.95B 2.3B 29.35B 2.25B 2.2B 94.29B 488M 745B 430M 406M 369M 692M 46.88B 696M 4.85B 1.87B 23.93B 1.83B 1.79B 76.87B
Logo Tempus AI, Inc.
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Employees
3,800
Date Price Change Volume
26-09-28 ARS 11,460.00 +0.09% 16,850
26-09-25 ARS 11,450.00 +3.81% 19,167
26-09-24 ARS 11,030.00 +7.71% 59,688
26-09-23 ARS 10,240.00 -0.10% 1,064
26-09-22 ARS 10,250.00 -1.25% 19,992
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
85.08USD
Average target price
68.56USD
Spread / Average Target
-19.42%

Quarterly revenue - Rate of surprise